News Release
November. 2, 2026
Ezaki Glico Co., Ltd.
Glico launches personalized health support service
-Alliance with US-based Viome provides food recommendations tailored to each individual based on mRNA analysis of the gut microbiome-
Ezaki Glico Co., Ltd. (hereinafter “Glico”) has partnered with US health tech company Viome Life Sciences, Inc. (headquartered in Washington State, USA; Founder & CEO: Naveen Jain; hereinafter “Viome”) to launch mRNA HEALTH TRACKER🄬（*1）, Japan’s first（*2） personalized health support service for individuals that utilizes gut microbiome mRNA testing（*3） and data analysis technology, on September 14.
The service assesses microbial activity to provide a detailed understanding of each individual’s gut microbiome activity,and displays 26 types of health scores and foods tailored to those scores, selected from a pool of over 300 candidate foods. Based on the results, users get recommendations on foods, supplements, and meal solutions. Glico’s expert personal advisors work closely with users to improve their diets and lifestyles, providing comprehensive support—from understanding gut microbiome activity to making the right food choices and behavior changes.
*1:This service does not involve the provision of pharmaceuticals, medical devices, or medical services,
nor is it intended for the detection, diagnosis, treatment, or prevention of users’ medical conditions.
*2:A personalized service aimed at maintaining and improving individual health through the use of mRNA
analysis technology, based on research conducted by Glico.
*3:A messenger ribonucleic acid (mRNA) molecule is a molecule that reflects gene activity.
By analyzing mRNA, gut microbiome functions can be better understood.